82 related articles for article (PubMed ID: 20075713)
1. Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung.
Buonerba C; Gallo C; Di Lorenzo G; Romeo V; Marinelli A
Anticancer Drugs; 2010 Apr; 21(4):465-8. PubMed ID: 20075713
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of neuroendocrine tumors of the lung.
Daddi N; Ferolla P; Urbani M; Semeraro A; Avenia N; Ribacchi R; Puma F; Daddi G
Eur J Cardiothorac Surg; 2004 Oct; 26(4):813-7. PubMed ID: 15450578
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic approach of carcinoid tumours of the lung.
Ruggieri M; Scocchera F; Genderini M; Mascaro A; Paolini A
Eur Rev Med Pharmacol Sci; 2000; 4(1-2):43-6. PubMed ID: 11409188
[TBL] [Abstract][Full Text] [Related]
4. Lung carcinoid tumor biology: treatment and survival.
Dahabreh J; Stathopoulos GP; Koutantos J; Rigatos S
Oncol Rep; 2009 Mar; 21(3):757-60. PubMed ID: 19212636
[TBL] [Abstract][Full Text] [Related]
5. Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
Oncology; 2001; 60(2):141-5. PubMed ID: 11244329
[TBL] [Abstract][Full Text] [Related]
6. The role of somatostatin analogs in the management of carcinoid tumors.
Tomassetti P; Migliori M; Campana D; Brocchi E; Piscitelli L; Tomassetti V; Corinaldesi R
J Endocrinol Invest; 2003; 26(8 Suppl):79-81. PubMed ID: 15233219
[No Abstract] [Full Text] [Related]
7. Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide.
Filosso PL; Ruffini E; Oliaro A; Rena O; Casadio C; Mancuso M; Turello D; Cristofori RC; Maggi G
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):819-24. PubMed ID: 15821649
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin analogues in the treatment of carcinoid].
Bednaríková M; Valík D; Vyzula R
Cas Lek Cesk; 2008; 147(4):233-5. PubMed ID: 18578378
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary carcinoid tumors].
Montresor E; Lupi A; Gorla A; Modena S; Sgrò M; Caneva A; Rossi S; Pea M; Frigo F; Puchetti V
Chir Ital; 1994; 46(3):29-36. PubMed ID: 8001191
[TBL] [Abstract][Full Text] [Related]
10. Hyperplasia of endocrine cells, tumorlets and atypical carcinoid of the lung--a case report.
Papla B; Zieliński M; Kuzdzał J; Harazda M
Pol J Pathol; 2004; 55(3):31-3. PubMed ID: 15619978
[TBL] [Abstract][Full Text] [Related]
11. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies.
Anthony LB; Woltering EA; Espenan GD; Cronin MD; Maloney TJ; McCarthy KE
Semin Nucl Med; 2002 Apr; 32(2):123-32. PubMed ID: 11965607
[TBL] [Abstract][Full Text] [Related]
12. An atypical lung carcinoid tumor resected after induction therapy with involvement of the superior sulcus region: report of a case.
Ohta Y; Toda A; Ohta N; Oda M; Minato H; Nonomura A; Watanabe G
Surg Today; 2002; 32(7):632-4. PubMed ID: 12111522
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid tumors of the lung: do atypical features require aggressive management?
Marty-Ané CH; Costes V; Pujol JL; Alauzen M; Baldet P; Mary H
Ann Thorac Surg; 1995 Jan; 59(1):78-83. PubMed ID: 7818364
[TBL] [Abstract][Full Text] [Related]
14. Carcinoid syndrome.
Zambrzycki JK; Elliott CG
Nurse Anesth; 1993 Dec; 4(4):198-201. PubMed ID: 7907889
[TBL] [Abstract][Full Text] [Related]
15. Metastatic carcinoid tumor: changing patterns of care over two decades.
Townsend A; Price T; Yeend S; Pittman K; Patterson K; Luke C
J Clin Gastroenterol; 2010 Mar; 44(3):195-9. PubMed ID: 19609217
[TBL] [Abstract][Full Text] [Related]
16. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
[TBL] [Abstract][Full Text] [Related]
18. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
20. A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review).
Comaru-Schally AM; Schally AV
Int J Oncol; 2005 Feb; 26(2):301-9. PubMed ID: 15645113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
